Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Therese J, Bocklage"'
NSD3::NUTM1 Fusion Sarcoma Mimicking Malignant Peripheral Nerve Sheath Tumor with Prolonged Survival
Autor:
Jing Di, Ali M. Alhaidary, Chi Wang, Jinge Liu, Sainan Wei, Joseph Valentino, Therese J. Bocklage
Publikováno v:
Biomedicines, Vol 12, Iss 8, p 1709 (2024)
Nuclear Protein in Testis (NUT)-rearranged tumors comprise predominantly NUT carcinoma but also include certain lymphomas, leukemias, skin appendage tumors, and sarcomas. Although histologically diverse, all are genetically identified by oncogenic re
Externí odkaz:
https://doaj.org/article/7e80947a0f62456e85c006988e4b7739
Publikováno v:
Human Pathology Reports, Vol 28, Iss , Pp 300639- (2022)
Extraskeletal osteosarcoma (EOS) is a sarcoma primary to soft tissue that produces tumor osteoid or bone (mineralized osteoid). It is rare, occurs generally in middle-aged to older adults in the extremities, and typically is histologically high grade
Externí odkaz:
https://doaj.org/article/2654b8d13c534ba5aee7ff6670d16791
Autor:
Teresa WM Fan, Richard M Higashi, Huan Song, Saeed Daneshmandi, Angela L Mahan, Matthew S Purdom, Therese J Bocklage, Thomas A Pittman, Daheng He, Chi Wang, Andrew N Lane
Publikováno v:
eLife, Vol 10 (2021)
Although Pembrolizumab-based immunotherapy has significantly improved lung cancer patient survival, many patients show variable efficacy and resistance development. A better understanding of the drug’s action is needed to improve patient outcomes.
Externí odkaz:
https://doaj.org/article/6541a0fc470f4f33989f246beecdeb72
Autor:
Tanner J. DuCote, Kassandra J. Naughton, Erika M. Skaggs, Therese J. Bocklage, Derek B. Allison, Christine F. Brainson
Publikováno v:
Laboratory Investigation. :100176
Autor:
Leah C, Pulling, Kevin K, Divine, Donna M, Klinge, Frank D, Gilliland, Terri, Kang, Ann G, Schwartz, Therese J, Bocklage, Steven A, Belinsky
Publikováno v:
Cancer research. 63(16)
Adenocarcinoma (AC) is the most common type of lung cancer diagnosed in the United States, comprising up to 40% of tumors in smokers and 50-80% of tumors in never-smokers. Exposures to cigarette smoke, direct or second-hand, and radiation in the form